Protocol amendments, recruitment delays, data quality issues, and operational bottlenecks are often discovered during study execution. That does not necessarily mean they originate there. In many cases, the underlying issue can be traced back to protocol decisions that seemed reasonable during study design but created unintended downstream consequences once sites, participants, and study teams began working within the protocol.
The challenge is that these risks are often difficult to spot when reviewing protocol sections independently. They become much more visible when viewed through the lens of data collection and study execution.
Protocol Decisions Have Operational Consequences
Protocols are evaluated based on scientific validity, regulatory requirements, and clinical objectives. Those considerations are essential, but every protocol decision also creates operational and data collection requirements.
Examples include:
- Eligibility criteria
- Assessment schedules
- Endpoint definitions
- Visit frequency
- Data collection requirements
Each decision may be justified on its own. The cumulative impact is where protocol complexity often emerges.
This is one reason protocol design can be so challenging. A study team may make dozens of individually reasonable decisions over the course of protocol development. A new assessment may strengthen an endpoint strategy. An additional eligibility criterion may improve population definition. Additional data collection may help answer important scientific questions. Viewed independently, each change can appear relatively minor. Viewed together, they can significantly influence recruitment, participant burden, site workload, data quality, and overall study execution.
The downstream effects are rarely immediate. They often become visible only after sites begin screening participants, conducting visits, collecting data, and managing protocol requirements in real-world settings. In some cases, these challenges ultimately contribute to protocol amendments when operational assumptions prove more difficult than anticipated during study execution.
Five Protocol Design Problems That Start Earlier Than Most Teams Realize
1. Restrictive Eligibility Criteria
Overly narrow inclusion and exclusion criteria can reduce the available participant population, increase screening failures, and extend recruitment timelines.
The challenge: the impact may not become fully apparent until sites begin screening participants. By that point, recruitment plans, timelines, and study startup efforts are already in motion.
2. Assessment Creep
Protocols often accumulate assessments over time as stakeholders add requirements during development.
The challenge: each additional assessment may seem reasonable, but collectively they can increase participant burden, site workload, and operational complexity. Small additions made throughout protocol development can have a much larger impact when combined into a single participant journey.
3. Endpoint Complexity
Endpoints may be scientifically valuable while still creating significant operational demands.
The challenge: endpoint operationalization, collection requirements, specialized procedures, and consistency across sites may be more difficult than anticipated. The operational effort required to support an endpoint is not always obvious during protocol review.
4. Site Burden
Protocol complexity ultimately lands at the site level.
The challenge: workflows that appear manageable during design may require substantial coordination during execution. Site teams are often responsible for navigating the cumulative impact of protocol decisions made across multiple stakeholder groups.
5. Missing Data Risk
Many missing data issues originate in study design rather than solely from participant behavior.
The challenge: complex schedules, burdensome assessments, difficult endpoint requirements, and competing site priorities can all contribute to incomplete data collection.
Why These Issues Are Difficult to Spot Early
Study teams typically review protocols from different perspectives:
- Clinical
- Medical
- Regulatory
- Statistical
- Operational
Each perspective is valuable, but no single group sees the entire picture.
Clinical teams focus on scientific objectives and patient populations. Biostatistics teams focus on endpoints and analysis plans. Regulatory stakeholders focus on compliance requirements. Operational teams focus on execution. Data management teams focus on how study data will ultimately be collected, reviewed, cleaned, reconciled, and prepared for analysis.
The challenge is that protocol risks often emerge at the intersection of these perspectives. A decision that makes sense from one viewpoint may create complexity elsewhere in the study. Because responsibilities are distributed across functions, the cumulative impact of protocol decisions is not always obvious during development.
Many protocol risks only become visible when requirements are translated into workflows, forms, assessments, schedules, and data collection processes. This is where downstream consequences often begin to emerge.
Protocol Feasibility Reviews Can Reveal Risks Sooner
One approach organizations increasingly use to manage protocol complexity is earlier protocol feasibility assessment. Rather than evaluating protocol sections independently, feasibility reviews examine how study requirements may affect recruitment, site operations, participant burden, data collection, and overall execution.
These reviews can help identify operational feasibility concerns before study start-up, when changes are generally easier and less costly to address. They also create opportunities for cross-functional discussion around recruitment assumptions, endpoint practicality, assessment schedules, and data collection requirements before they are embedded into study workflows.
While protocol feasibility reviews cannot eliminate complexity, they can help organizations better understand where complexity exists and whether adjustments may improve study performance.
A Shift Toward Earlier Evaluation in Study Design
The industry has spent years investing in Quality by Design (QbD), risk-based quality management (RBQM), and more proactive planning. Increasingly, organizations are asking whether protocol risks can be identified before they affect recruitment, data quality, study timelines, participant experience, or site performance.
This shift creates an opportunity for earlier cross-functional review, including greater input from data management and operational teams during protocol development. The objective is not to eliminate complexity from clinical trials. Many studies are inherently complex. The objective is to better understand where complexity exists, how it may affect execution, and whether adjustments can improve study performance before startup activities begin.
How AI Can Support Protocol Evaluation
As organizations look for new ways to evaluate protocol complexity, artificial intelligence is beginning to emerge as a potential tool for identifying operational risks earlier in the study design process.
AI-driven approaches may help study teams explore how protocol decisions could affect recruitment, participant burden, site workload, endpoint feasibility, and data collection requirements before study start-up. Combined with AI study simulation and cross-functional review, these capabilities may provide additional insight into where protocol complexity could create downstream challenges.
While human expertise remains essential, AI has the potential to help teams evaluate protocol designs more efficiently and identify risks that may otherwise emerge later during execution.
Building Stronger Studies from the Start
Many of the most expensive challenges in clinical research do not begin during study execution. They begin during study design, often as reasonable decisions that create unintended complexity when combined within a real-world protocol.
The earlier organizations can evaluate study designs through the lens of execution, data collection, participant experience, and operational feasibility, the greater their opportunity to improve study quality, reduce risk, and strengthen overall performance.
Interested in how AI may help study teams identify protocol complexity and operational risks earlier in the design process? Get in touch with us today.
